InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by SHALLCROSS STEVEN A, Chief Executive Officer. Insider active across 1 companies, notably Synthetic Biologics, Inc.. Cumulatively, 2 filings have been logged. Total volume traded: €41k. The latest transaction was disclosed on 10 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€20,25850,000 shares@ €0.4052100.0% of flow
Common Stock
SEC:0001104659-21-064047·
Ideal exit: 4 Feb 2022 (T+270)
€20,25850,000 shares@ €0.405250.0% of flow
Common Stock
SEC:0001104659-21-064047:0·
Ideal exit: 4 Feb 2022 (T+270)
2 of 2 declarations
About SHALLCROSS STEVEN A
Steven A. Shallcross is the Chief Executive Officer and Chief Financial Officer of Synthetic Biologics, Inc. He oversees the financial and strategic operations of the company, playing an essential role in growth and innovation.
